The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBbva Ord Regulatory News (BVA)

Share Price Information for Bbva Ord (BVA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.02
Bid: 10.04
Ask: 10.52
Change: 0.13 (1.31%)
Spread: 0.48 (4.781%)
Open: 10.02
High: 10.02
Low: 10.02
Prev. Close: 9.89
BVA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2023 EBA Stress Test

28 Jul 2023 18:17

RNS Number : 6322H
Banco Bilbao Vizcaya Argentaria SA
28 July 2023
 

 

 

 

Banco Bilbao Vizcaya Argentaria, S.A. (BBVA), in compliance with the Securities Market legislation, hereby communicates the following:

OTHER RELEVANT INFORMATION

BBVA has been subject to the 2023 EU-wide Stress Test conducted by the European Banking Authority (EBA), in cooperation with the European Central Bank (ECB) and the European Systemic Risk Board (ESRB).

The 2023 EU-wide Stress Test does not contain a pass/fail threshold, instead it is designed to be used as an important source of information for the Supervisory Review and Evaluation Process (SREP) in 2023. The results allow competent authorities to assess BBVA's ability to meet the regulatory capital requirements under stressed scenarios based on common methodological assumptions.

The adverse stress test scenario was set by the ECB and the ESRB covering a three-year time horizon (2023-2025) and the stress test scenario has been carried out applying a static balance sheet assumption as of December 31st, 2022. Therefore the stress test scenario does not take into account business strategies and management actions implemented after the cut-off date.

BBVA's results are summarized below:

● Under the baseline scenario, BBVA's CET1 fully loaded ratio would increase by 3.26 percentage points from December 31st 2022, reaching a maximum level of 15.87% as of December 31st 2025.

● Under the adverse scenario, BBVA's CET1 fully loaded ratio would be reduced by 2.95 percentage points from December 31st 2022, reaching a minimum level of 9.66% as of December 31st 2025.

Further information is available on the EBA website (www.eba.europa.eu)

Madrid, July 28th 2023

 

 

Note: The stress test exercise information is provided in the accompanying disclosure tables based on the common format provided by the EBA. The EU-stress test exercise and its results are not a forecast of BBVA profits.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCRPMRTMTBTBTJ
Date   Source Headline
1st Feb 20187:02 amRNS4Q17 Results Press Release
1st Feb 20187:00 amRNSProposal for payment of dividend
25th Jan 20185:25 pmRNS4Q17 Results Presentation Announcement
10th Jan 20187:00 amRNSAssessment of the shareholding at Telefonica, S.A
28th Dec 20173:26 pmRNSGMTN Programme Supplement to the Offering Circular
27th Dec 201712:59 pmRNSGMTN Programme - Issuer Substitution
27th Dec 201712:42 pmRNSGMTN Programme
21st Dec 20176:29 pmRNSPost Stabilisation Notice
15th Dec 20174:00 pmRNSPublication of approved ECP Information Memorandum
13th Dec 20175:35 pmRNSSREP Capital Requirements 2018
5th Dec 20177:22 amRNSTransmissions and purchases of capital undertaking
4th Dec 201710:47 amRNSFinal Terms 154SNP
29th Nov 20178:13 amRNSSale of real estate business
28th Nov 20177:00 amRNSBinding offer for the acquisition of BBVA Chile
24th Nov 20171:25 pmRNSFinal Terms 153SNP
10th Nov 201712:31 pmRNSFinal Terms Global Medium Term Note Programme
9th Nov 20177:00 amRNSAT1 Issuance for a total nominal amount
8th Nov 201710:52 amRNSPre Stabilisation Notice
7th Nov 20171:10 pmRNSOffer of securities contingently convertible
27th Oct 20174:29 pmRNSGMTN programme Supplement to the Offering Circular
27th Oct 20177:00 amRNSBBVA communicates its 3Q17 results press release
27th Oct 20177:00 amRNSBBVA communicates its 3Q17 results report
27th Oct 20177:00 amRNSBBVA communicates its 3Q17 results presentation
23rd Oct 20175:33 pmRNS3Q17 Results Presentation Announcement
6th Oct 201711:39 amRNSPost Stabilisation Notice BBVA EUR 5yr SNP
28th Sep 20177:55 amRNSHR News Real Estate
28th Sep 20177:00 amRNSDividend October 2017
4th Sep 20174:33 pmRNSFinal Terms 152 Execution version
31st Aug 20177:47 amRNSBBVA Chile News
30th Aug 20178:30 amRNSPre Stabilisation Notice BBVA 5yr EUR SNP
2nd Aug 20177:57 amRNSDBRS upgrades BBVA´s Cédulas Hipotecarias rating
1st Aug 201712:53 pmRNSFinal Supplement 2Q17
27th Jul 20176:04 pmRNS2Q17 Results Report
27th Jul 20175:46 pmRNS2Q17 Results Presentation
27th Jul 20175:30 pmRNS2Q17 Results Press Release
25th Jul 20175:39 pmRNSScope upgrades BBVA's senior unsecured rating
20th Jul 20175:18 pmRNSResults Presentation Announcement
12th Jun 20177:00 amRNSDBRS changes subordinated debt ratings
1st Jun 20177:00 amRNSBoard of Directors changes
25th May 201712:32 pmRNSFinal Terms GMTN151SUB
25th May 201711:26 amRNSFinal Terms
17th May 20177:00 amRNSAT1 Issuance
5th May 201712:55 pmRNSDividend Option
3rd May 201711:58 amRNSsupplemental to the Offering Circular
28th Apr 20178:43 amRNS2016 Audited Financial Statements
27th Apr 20177:00 amRNS1Q17 Results Report
27th Apr 20177:00 amRNS1Q17 Results Presentation
27th Apr 20177:00 amRNS1Q17 Press Release
24th Apr 20177:00 amRNSEnding trading period Dividend Option April 2017
21st Apr 20175:44 pmRNS1Q17 Results Presentation Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.